MedPath

Erbium-YAG Laser Versus Platelet Rich Plasma in the Treatment of Atrophic Acne Scars

Not Applicable
Completed
Conditions
Acne Vulgaris
Scars
Interventions
Device: Fractional Erbium Yağ Laser
Procedure: Platelet Rich Plasma
Registration Number
NCT03933033
Lead Sponsor
Aswan University Hospital
Brief Summary

This study aim to assess the efficacy of Er-YAG laser 2940nm and PRP as a single line of treatment in comparison with combined treatment in atrophic post acne scars.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
75
Inclusion Criteria
  • patients with atrophic post acne scars classified on the basis of Goodman and Baron's Qualitative classification, no active acne lesions and patients with atrophic scars only
Exclusion Criteria
  • patients with positive history of keloidal tendency, positive history of bleeding tendency, platelet disorder, patients with any acute infection on face like, herpes, folliculitis, patients with HIV, HBsAg, patients with a history of autoimmune diseases or patients on immunosuppressive drugs.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group CFractional Erbium Yağ Lasertreated with both line of treatments
Group BFractional Erbium Yağ Lasertreated with Erbium Yag Laser
Group APlatelet Rich Plasmatreated with platelet rich plasma
Group CPlatelet Rich Plasmatreated with both line of treatments
Primary Outcome Measures
NameTimeMethod
Change in grade of acne scares according toQualitative scarring grading system of Goodman and Baron6 months

Grade of acne scares improvement after treatment

Change in patient satisfaction usinga four-point scale; Grade 4 highly satisfied, Grade 3 satisfied, Grade 2 neutral and Grade 1 dissatisfied6 month

increase in patient satisfaction after treatment

Change in clinical appearance of acne scare accordinga four-point scale for assessment of clinical improvement of skin smoothness6 month

improvement of acne scares as evaluated by sequential photos

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Aswan University Hospital

🇪🇬

Aswan, Egypt

© Copyright 2025. All Rights Reserved by MedPath